{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:05:59Z","timestamp":1778238359772,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001314","name":"Durham University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/P027989\/1"],"award-info":[{"award-number":["MR\/P027989\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ijpddr.2019.05.003","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T20:59:22Z","timestamp":1560200362000},"page":"118-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Mining for natural product antileishmanials in a fungal extract library"],"prefix":"10.1016","volume":"11","author":[{"given":"A.J.","family":"Mbekeani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.S.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bassas Llorens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Elliot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Regnault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.K.","family":"Wrigley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.W.","family":"Denny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2019.05.003_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpddr.2017.04.003","article-title":"Functional and genetic evidence that nucleoside transport is highly conserved in Leishmania species: implications for pyrimidine-based chemotherapy","volume":"7","author":"Alzahrani","year":"2017","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1515\/znc-2002-3-411","article-title":"Studies on the biosynthesis of striatal-type diterpenoids and the biological activity of herical","volume":"57c","author":"Anke","year":"2002","journal-title":"Z Natursforsch"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bmcl.2009.11.033","article-title":"In vitro and in vivo anti-Leishmania activity of polysubstituted synthetic chalcones","volume":"20","author":"Aponte","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib4","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1128\/AAC.49.5.1679-1687.2005","article-title":"Antileishmanial activity of the terpene nerolidol","volume":"49","author":"Arruda","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Pt 1","key":"10.1016\/j.ijpddr.2019.05.003_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0031182000078458","article-title":"Complete developmental cycle of Leishmania mexicana in axenic culture","volume":"108","author":"Bates","year":"1994","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib6","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.bmc.2005.10.005","article-title":"Synthesis of chalcone analogues with increased antileishmanial activity","volume":"14","author":"Boeck","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pt.2012.05.005","article-title":"Purine salvage in Leishmania: complex or simple by design?","volume":"28","author":"Boitz","year":"2012","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib8","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1039\/C6MD00060F","article-title":"Enlarging the chemical space of anti-leishmanials: a structure-activity relationship study of peptoids against Leishmania mexicana, a causative agent of cutaneous leishmaniasis","volume":"7","author":"Bolt","year":"2016","journal-title":"Med.Chem.Comm"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1471-4922(03)00069-2","article-title":"Pentamidine uptake and resistance in pathogenic protozoa: past, present and future","volume":"19","author":"Bray","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/psc.1398","article-title":"Studies on the antileishmanial properties of the antimicrobial peptides temporin A, B and 1Sa","volume":"17","author":"Chadbourne","year":"2011","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S0031182017000993","article-title":"Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art","volume":"145","author":"Charlton","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib14","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/AAC.38.6.1339","article-title":"Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani","volume":"38","author":"Chen","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib15","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1021\/acs.jnatprod.8b00159","article-title":"Active natural product scaffolds against trypanosomatid parasites: a review","volume":"81","author":"Cockram","year":"2018","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib16","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/bioinformatics\/bts069","article-title":"IDEOM: an Excel interface for analysis of LC-MS-based metabolomics data","volume":"28","author":"Creek","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib17","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.1021\/ac2021823","article-title":"Toward global metabolomics analysis with hydrophilic interaction liquid chromatography-mass spectrometry: improved metabolite identification by retention time prediction","volume":"83","author":"Creek","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.exppara.2012.01.015","article-title":"The leishmanicidal flavonols quercetin and quercitrin target Leishmania (Leishmania) amazonensis arginase","volume":"130","author":"da Silva","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.exppara.2013.11.003","article-title":"Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis","volume":"136","author":"de Mello","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1128\/AAC.48.1.100-103.2004","article-title":"Oral delivery of meglumine antimoniate-beta-cyclodextrin complex for treatment of leishmaniasis","volume":"48","author":"Demicheli","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jac\/44.1.71","article-title":"Flow cytometric assessment of amphotericin B susceptibility in Leishmania infantum isolates from patients with visceral leishmaniasis","volume":"44","author":"Di Giorgio","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib24","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1128\/AAC.47.6.1895-1901.2003","article-title":"Antileishmanial activity of a linalool-rich essential oil from Croton cajucara","volume":"47","author":"do Socorro","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 1","key":"10.1016\/j.ijpddr.2019.05.003_bib25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1378\/chest.54.Supplement_1.296","article-title":"The discovery and development of amphotericin B","volume":"54","author":"Dutcher","year":"1968","journal-title":"Dis. Chest"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cmdc.201402416","article-title":"Investigating the anti-leishmanial effects of linear peptoids","volume":"10","author":"Eggimann","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/znc-1998-1-216","article-title":"Nitidon, a new bioactive metabolite from the basidiomycete Junghuhnia nitida (Pers","volume":"53","author":"Gehrt","year":"1998","journal-title":"Fr.) Ryv. Z. Naturforsch. C"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1099-1573(199705)11:3<193::AID-PTR68>3.0.CO;2-R","article-title":"Leishmanicidal and trypanocidal activity of extracts and secondary metabolites from basidiomycetes","volume":"11","author":"Inchausti","year":"1997","journal-title":"Phytother Res."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/092986709787458489","article-title":"Leishmaniasis: current treatment and prospects for new drugs and vaccines","volume":"16","author":"Kedzierski","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature19339","article-title":"Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness","volume":"537","author":"Khare","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006953","article-title":"Deletion of transketolase triggers a stringent metabolic response in promastigotes and loss of virulence in amastigotes of Leishmania mexicana","volume":"14","author":"Kov\u00e1\u0159ov\u00e1","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/mmi.13390","article-title":"A role for adenine nucleotides in the sensing mechanism to purine starvation in Leishmania donovani","volume":"101","author":"Martin","year":"2016","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/138955709787001758","article-title":"Fighting against Leishmaniasis: search of alkaloids as future true potential anti-Leishmanial agents","volume":"9","author":"Mishra","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF03401792","article-title":"Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis","volume":"6","author":"Mittra","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib35","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1038\/s41598-018-22063-9","article-title":"Identifying inhibitors of the Leishmania inositol phosphorylceramide synthase with antiprotozoal activity using a yeast-based assay and ultra-high throughput screening platform","volume":"8","author":"Norcliffe","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib36","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1038\/srep08771","article-title":"New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource","volume":"5","author":"Pena","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib38","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1021\/ac2000994","article-title":"PeakML\/mzMatch: a file format, Java library, R library, and tool-chain for mass spectrometry data analysis","volume":"83","author":"Scheltema","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib39","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.7164\/antibiotics.47.1284","article-title":"New nematicidal and antimicrobial compounds from the basidiomycete Cheimonophyllum candidissimum (Berk & Curt.) sing. I. Producing organism, fermentation, isolation, and biological activities","volume":"47","author":"Stadler","year":"1994","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib40","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI33945","article-title":"Kinetoplastids: related protozoan pathogens, different diseases","volume":"118","author":"Stuart","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis chemical analysis working group (CAWG) metabolomics standards initiative (MSI)","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0035-9203(99)90037-8","article-title":"Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases","volume":"93","author":"Thakur","year":"1999","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2019.05.003_bib43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1087057114551519","article-title":"Metabolomic-based strategies for anti-parasite drug discovery","volume":"20","author":"Vincent","year":"2015","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib44","first-page":"e1618","article-title":"Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against Trypanosoma brucei","volume":"6","author":"Vincent","year":"2012","journal-title":"PLoS NTD"},{"key":"10.1016\/j.ijpddr.2019.05.003_bib45","doi-asserted-by":"crossref","first-page":"39925","DOI":"10.1074\/jbc.M405635200","article-title":"Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani","volume":"279","author":"Wyllie","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320719300260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320719300260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:51:09Z","timestamp":1761922269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320719300260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":45,"alternative-id":["S2211320719300260"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2019.05.003","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mining for natural product antileishmanials in a fungal extract library","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2019.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}